SALT LAKE CITY, June 30, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, today announced that it was added to the Russell Microcap Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indices on June 27, 2014.
“We are pleased to be added to the Russell Microcap Index and believe that this inclusion will lead to increased awareness of Lipocine among the institutional investor community,” said Dr. Mahesh Patel, President and CEO of Lipocine Inc.
Help employers find you! Check out all the jobs and post your resume.
